The genetic basis of healthy aging and longevity remains largely unexplained. One hypothesis as to why long-lived individuals do not appear to have a lower number of common-complex disease variants, is that despite carrying risk variants, they express disease-linked alleles at a lower level than the wild-type alleles. Allele-specific abundance (ASA) is the different transcript abundance of the two haplotypes of a diploid individual. We sequenced the transcriptomes of four healthy centenarians and four midlife controls. CIBERSORT was used to estimate blood cell fractions: neutrophils were the most abundant source of RNA, followed by CD8+ T cells, resting NK cells, and monocytes. ASA variants were more common in non-coding than coding regions.
Introduction
Several studies have shown that long-lived individuals do not appear to carry a substantially lower number of common-complex disease risk alleles compared to typical individuals (1) (2) (3) . It may be that despite carrying risk alleles, they express the diseaserelated variants at a lower level. Allele-specific abundance (ASA) is the different transcript abundance of the two haplotypes of a diploid individual. ASA occurs across the genome in different biological processes and across multiple tissues (4) . ASA can be caused by allele-specific alternative splicing, variation in transcriptional start or stop sites, cis-acting regulatory variants, epigenetic differences such as imprinting, DNA methylation, chromatin state, and differences in mRNA stability (4) . ASA has been shown to be under genetic control in a study using lymphoblastoid cell lines (LCL), where monozygotic twins were found to have a more similar degree of ASA than unrelated controls (5) .
Although different tissues have been shown to have important differences in expression, whole blood (WB) analysis has advantages. Peripheral blood is a cost-effective and clinically relevant tissue, it provides an overall view of the body since it comes into contact with almost all organs and tissues (6) , and it is useful when looking for biomarkers for diseases where the tissue of interest is not readily available. Studies using WB collected in PAXgene tubes have identified and validated a gene expression signature that distinguished between Alzheimer's Disease (AD) patients and cognitively healthy controls, showing that AD could be detected away from the primary site of the disease (7) . Mutations causing expression differences in cardiac-restricted genes for Long QT Syndrome, Marfan Syndrome, and hypertrophic cardiomyopathy were also identified from WB from PAXgene tubes (8) . WB is an appropriate tissue in which to assess overall patterns of ASE that may contribute to disease.
In a pilot study of four healthy centenarians and four mid-life controls, we hypothesized that the healthy centenarians may exhibit an overall pattern of lower expression of disease-associated alleles. This would effectively allow them to favour expression of nonrisk alleles, despite carrying disease-causing variants. Heterozygous SNPs in the transcribed region of a gene may be used as indicators to determine if one copy of the gene is more highly expressed than the other. We tested whether preferential transcript abundance was observed, and whether it was skewed in centenarians versus controls by examining ASA in disease-associated genes and variants.
Methods

The Super-Seniors Study
Super-Seniors are aged 85 years and older with no reported history of cancer, cardiovascular disease (CVD), diabetes, major pulmonary disease, or dementia (9) . Four Super-Senior centenarians aged 100-104 years, and four controls aged 50-56 years who were not selected for health, participated in a transcriptome pilot study. Research ethics board (REB) approval was received from the joint Clinical REB of BC Cancer and the University of British Columbia, and the REB of Simon Fraser University. Participants gave written informed consent.
Sample preparation
WB was collected in PAXgene tubes, which preserve in vivo transcription levels. RNA was extracted using the PAXgene blood miRNA kit (QIAGEN) and globin depleted using the GLOBINclear™ kit (Thermo Fisher Scientific, Massachusetts, USA).
Transcriptome and exome libraries were constructed using the Illumina TruSeq stranded mRNA kit and Agilent Technologies SureSelect v4+UTR kit, respectively. Variants with ASA were compared by SNPEff predicted effect (11) and by major or minor allele bias as determined from minor allele frequencies reported in dbSNP (12) .
Gene lists were entered into QIAGEN Ingenuity® Pathway Analysis (IPA) to determine enriched pathways and physiological functions. To look for disease associations we compared genes showing ASA to lists of publically available disease-associations. We looked for evidence of ASA in the 60 genes recommended by ACMG for reporting of incidental findings (13) , as well as variants with SNP-trait associations that reached genome-wide significance listed in the NHGRI-EBI GWAS catalog v1.0.1 (14) . Variants with ASA were input into SNP2TFBS to map SNPs to transcription factors (TF) (15) .
Results
CIBERSORT estimated the mean major cell types to be neutrophils, followed by CD8+ T cells, monocytes, and resting natural killer cells (Supplementary Figure S1 and Table S1 ).
After transcriptome alignment there were ~240-320 million mapped reads per sample. with SNPs in the NHGRI-EBI GWAS catalog. Trait associations from the catalog were filtered to keep only associations with diseases that were exclusion criteria for SuperSeniors. 21 disease-associated SNPs remained. Of these, 9 were skewed to the minor allele and 12 were skewed to the major allele. 7 were skewed towards the allele associated with disease, 9 were skewed away from the allele associated with disease, and 5 did not have a clear disease-associated allele (Table 1) . 7 SNPs had ASA in multiple subjects, all of which were skewed in the same direction.
There were 3373 genes where ASA was observed in either centenarians or controls. Among the 60 'ACMG' genes, we found that centenarians and controls showed ASA ≥ 0.7:0.3 in 8 and 11 genes, respectively ( Table 2) . Of note, in LDLR ASA was observed in 1 centenarian and all 4 controls; and in TMEM43 ASA was observed in 3 centenarians and no controls. All other ASA variants in ACMG genes were unique with the exception of two SNPs in PRKAG2, which were each present in two subjects. One variant had a high predicted functional impact: a TTCT>TTCTCT indel at chr18:31068033 in DSC2. Table S3 ). ZBTB33, Tcfcp2l1, NHLH1, TFAP2C, Pax2 were the top 5 most enriched TFs.
unique variants with rsIDs were entered into SNP2TFBS (15). TF enrichment was determined by the ratio (total TF sites identified by SNP2TFBS): (TFs identified in the input list) (Supplementary
Discussion
Greater RD increases the power to detect subtler ASA. Li et al. (16) calculated that at a RD of 30 there is ~60% statistical power to detect an allelic ratio of 0.7:0.3. An RD of 30 provides ~90% power to detect an allelic ratio of 0.8:0.2, and nearly 100% power to detect an allelic ratio of 0.9:0.1. They further calculated that to achieve RD of 30 in ~90% of exonic variants would require ~190 million reads, whereas to achieve RD of 30 in ~95% of exonic variants would require ~240 million reads. Since this is an exploratory study, to detect allelic ratios with a difference ≥ 0.7:0.3, samples were sequenced to 330-400 million raw reads per sample.
The main components of WB are red blood cells (RBC), platelets, and white blood cells.
RBCs contribute globin transcripts which have been found to make up on average 60% of the mRNA transcripts of WB; however, after globin reduction this decreases to 0.1-0.4% (6) . White blood cells are comprised of numerous cell types including neutrophils, eosinophils, basophils, lymphocytes, and monocytes. Some studies utilize LCLs immortalized by Epstein-Barr virus (EBV), but gene expression has been shown to vary greatly between LCL and WB samples (17) . While LCLs are simpler to interpret because they represent a single cell type, they may be less likely to reflect in vivo expression levels due to expression changes during EBV transformation (18) and degradation between cell collection and RNA preparation (19) .
Overall, we found that centenarians and controls had a comparable distribution of ASA variants with no difference in proportion by predicted effect. ASA variants were more common in non-coding than coding regions. We did not observe an overall bias in expression towards the major or minor alleles in centenarians or controls.
Immune pathways were most highly represented among the gene set that showed ASA.
Immunosenescence is seen in the adaptive as well as innate immune systems (20) . The occurrence of immune dysfunction with aging is well established, including increased susceptibility to infection, frequency of neoplasia, inflammation, and autoimmune response (21) . A common factor underlying the pathogenesis of many age-related chronic diseases including CVD, cancer, neurodegenerative diseases, and diabetes is inflammation (20) . It has been previously suggested that centenarians may have genetic factors that allow them to better maintain immune function as they age (22, 23) .
When looking at ACMG genes with potential clinical utility (13), we found evidence of ASA in some genes related to disease etiology. Although it may be an artifact of small sample size, LDLR, for which ASA was observed in 1 centenarian and all 4 controls, and TMEM43, for which ASA was observed in 3 centenarians and no controls, are potentially interesting to look at in a larger study. LDLR is associated with familial hypercholesterolemia and is a major apoE receptor; variants of the APOE gene are the most replicated association with longevity and healthy aging phenotypes (24) including the Super-Senior phenotype (25) . TMEM43 is associated with arrhythmogenic right ventricular cardiomyopathy, type 5. ASA variants also overlapped with diseaseassociated NHGRI-EBI GWAS catalogue variants. It is possible that among patients with disorders associated with these genes, even when a pathogenic variant is not identified, ASA may be playing a role in disease pathogenicity if a cis-acting factor is affecting gene expression. There was evidence that ASA variants overlapped with numerous TFs, which are possible mechanisms for cis-acting affects.
A caveat to the ASA that we observed is that it may not reflect true in vivo RNA expression levels. As well, ASA can be caused by numerous mechanisms that cannot be distinguished in the present study. It is possible that some of our observed cases of ASA could be the result of alternative transcripts that have been collapsed into single loci.
As a pilot study, the sample size was very small, and may lead to false negative findings.
We did not find evidence for a pattern of lower expression of disease-associated variants in centenarians compared to mid-life controls. The presence of ASA in some ACMG genes suggests that in patients with disorders that are highly associated with a certain gene, but for which no causal variant is apparent, looking at ASA may be of interest. As well, the representation of immune pathways among the ASA gene set of centenarians may be related to decreased immune function with aging.
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